Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2018 | 3 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes.
Drug Metab Dispos. 2018 Feb;46(2):131-140. doi: 10.1124/dmd.117.078048. Epub 2017 Nov 21.
Drug Metab Dispos. 2018.
PMID: 29162613
Free article.
mRNA Expression and Activity of Nucleoside Transporters in Human Hepatoma HepaRG Cells.
Mayati A, Moreau A, Jouan E, Febvre-James M, Denizot C, Parmentier Y, Fardel O.
Mayati A, et al. Among authors: febvre james m.
Pharmaceutics. 2018 Nov 21;10(4):246. doi: 10.3390/pharmaceutics10040246.
Pharmaceutics. 2018.
PMID: 30469356
Free PMC article.
Item in Clipboard
Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes.
Febvre-James M, Lecureur V, Fardel O.
Febvre-James M, et al.
Inflamm Res. 2020 Jan;69(1):51-62. doi: 10.1007/s00011-019-01293-1. Epub 2019 Oct 25.
Inflamm Res. 2020.
PMID: 31654094
Item in Clipboard
Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages.
Febvre-James M, Lecureur V, Augagneur Y, Mayati A, Fardel O.
Febvre-James M, et al.
Int Immunopharmacol. 2018 Jan;54:354-365. doi: 10.1016/j.intimp.2017.11.032. Epub 2017 Dec 1.
Int Immunopharmacol. 2018.
PMID: 29202299
Item in Clipboard
Cite
Cite